BENINI, Anna
 Distribuzione geografica
Continente #
EU - Europa 12.033
NA - Nord America 8.382
AS - Asia 5.271
SA - Sud America 649
AF - Africa 42
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 10
Totale 26.406
Nazione #
US - Stati Uniti d'America 8.303
IT - Italia 4.548
RU - Federazione Russa 2.475
SG - Singapore 2.306
GB - Regno Unito 2.074
CN - Cina 1.754
FR - Francia 565
BR - Brasile 540
DE - Germania 516
SE - Svezia 504
FI - Finlandia 420
HK - Hong Kong 385
IE - Irlanda 369
VN - Vietnam 239
UA - Ucraina 202
KR - Corea 177
NL - Olanda 109
JP - Giappone 82
BE - Belgio 54
AR - Argentina 49
TR - Turchia 45
IN - India 40
CA - Canada 38
ID - Indonesia 38
PL - Polonia 35
IR - Iran 34
ES - Italia 28
RO - Romania 28
MX - Messico 26
IQ - Iraq 25
CH - Svizzera 23
SA - Arabia Saudita 21
BD - Bangladesh 19
EC - Ecuador 18
AU - Australia 17
PK - Pakistan 15
IL - Israele 12
LT - Lituania 12
ZA - Sudafrica 12
CL - Cile 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
CO - Colombia 8
EG - Egitto 8
EU - Europa 7
JO - Giordania 7
MA - Marocco 7
PE - Perù 7
TN - Tunisia 7
TW - Taiwan 7
AT - Austria 6
BG - Bulgaria 6
PT - Portogallo 6
PY - Paraguay 6
BY - Bielorussia 5
DK - Danimarca 5
KE - Kenya 5
NP - Nepal 5
OM - Oman 5
VE - Venezuela 5
AL - Albania 4
AZ - Azerbaigian 4
BO - Bolivia 4
KZ - Kazakistan 4
MK - Macedonia 4
PA - Panama 4
PH - Filippine 4
QA - Qatar 4
AM - Armenia 3
EE - Estonia 3
GR - Grecia 3
HU - Ungheria 3
LU - Lussemburgo 3
TH - Thailandia 3
DO - Repubblica Dominicana 2
GE - Georgia 2
HR - Croazia 2
JM - Giamaica 2
LK - Sri Lanka 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BT - Bhutan 1
BZ - Belize 1
CR - Costa Rica 1
DZ - Algeria 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IM - Isola di Man 1
Totale 26.394
Città #
Southend 1.764
Jacksonville 1.497
Singapore 1.191
Chandler 1.136
Moscow 707
Woodbridge 685
Ashburn 561
Dallas 547
Ann Arbor 530
Hong Kong 380
Dublin 367
Houston 359
Verona 280
Milan 242
Rome 229
Beijing 199
Lawrence 177
Princeton 177
Wilmington 175
New York 162
Nanjing 151
Jinan 137
Shenyang 131
The Dalles 129
Los Angeles 117
Sindelfingen 113
Munich 89
Boardman 84
Buffalo 84
Tianjin 81
Tokyo 80
Hebei 79
Bologna 76
Ho Chi Minh City 74
Ningbo 61
Changsha 59
Naples 57
Helsinki 56
Brussels 52
Hanoi 50
Zhengzhou 49
Haikou 48
São Paulo 48
Nanchang 47
Florence 45
Seattle 45
Council Bluffs 42
Hangzhou 39
Santa Clara 37
Turin 36
Guangzhou 35
Columbus 34
Jiaxing 33
Palermo 33
Taizhou 31
Chicago 29
Redondo Beach 29
San Jose 28
Lanzhou 26
Norwalk 26
Bari 25
Redwood City 25
Napoli 23
Taiyuan 23
Frankfurt am Main 21
Padova 21
San Francisco 21
Jakarta 20
Rio de Janeiro 20
Turku 20
Warsaw 20
Fuzhou 19
Genoa 19
London 18
Riyadh 18
Genova 17
Belo Horizonte 16
Brescia 16
Fairfield 16
Lancaster 16
Torino 16
Brasília 15
Catania 15
Monza 15
Seoul 15
Toronto 15
Augusta 14
Curitiba 14
Dong Ket 14
Parma 14
Stockholm 14
Atlanta 13
Brooklyn 13
Cagliari 13
Pescara 13
Pisa 13
Redmond 13
San Mateo 13
Trieste 13
Bergamo 12
Totale 14.536
Nome #
Infezione da Klebsiella pneumoniae carbapenemasi produttrice: dati preliminari di dosaggio di tigeciclina, meropenem e colistina in plasma di pazienti ricoverati in terapia intensiva mediante cromatografia liquida ad alte prestazioni accoppiata a spettrometria di massa tandem 3.947
Proprietà farmacocinetiche e farmacodinamiche di antibiotici nel trattamento locale di infezioni protesiche 319
Influenza del sito d’ infezione (pancreas) sulla farmacocinetica e farmacodinamica di piperacillina-tazobactam 237
Analysis of intestinal microflora of autistic children before and after probiotic treatment. 222
Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. 207
Effetti del calcio policarbofil nel bambino con stipsi 203
Variability in the release of antibiotics from PMMA bone cement spacers 200
Antibiotics penetration in human necrotizing pancreatitis (NP). 199
Health-promoting properties of new lactobacilli strains: in vivo models 192
Effect of dose on the intestinal concentrations of fluoroquinolones. Infection and Intensive care. Italian and British Perspectives 190
Farmacocinetica e farmacodinamica di piperacillina–tazobactam in pazienti con fistola pancreatica esterna 190
Antibiotics and intestinal contents interaction 189
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in human pancreas 184
Different probiotics and intestinal microflora in antibiotic treated children 184
Fluoroquinolones effects on patients lymphocytes during prolonged treatments 183
Antibiotic Release from removed temporary hip spacers 180
Effetti dei fluorochinoloni in linfociti di pazienti in trattamenti protratti. 178
Commercial probiotic products: evaluation of microbial content and nomenclature 177
Safery and antibiotics concentrations in serum and urine after implantation of gentamicin-vancomycin-loaded spacers in patients with prosthetic joint infections 175
Twice-weekly dapsone for primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1 infection: efficacy, safety and pharmacokinetic data 175
FLUOROQUINOLONES: EFFECTS OF DOSE ON INTESTINAL PENETRATION, HEPATIC ISOFORMS AND DNA DAMAGE IN RAT. 174
FLUOROQUINOLONES: EFFECTS OF DOSE ON INTESTINAL PENETRATION, HEPATIC ISOFORM AND DNA DAMAGE IN RAT. 169
Challenges and opportunities by bridging human and animal surveillance to tackle antimicrobial resistance 169
Diffusione ossea dell'associazione gentamicina-vancomicina da impianto in PMMA in osteomielite sperimentale 167
Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation 167
Antibiotici e pancreas esocrino: interazioni. 166
Antimicrobial activity of gentamicin and vancomycin combination in joint fluids after antibiotic-loaded cement spacer implantation in two-stage revision surgery. 164
Evaluations of CYP 3A 4/5 and DNA damage in rat enterocytes and in human and rat lymphocytes by fluoroquinolones 164
Bacterial faecal flora in healthy women of different ages. 163
Bacterial flora composition and faecal enzymes in pre- and postmenopausal women with breast cancer. 163
Antibiotics and their interaction with intestinal contents. 161
Effect of ceftriaxone along with probiotics administrationon intestinal ecosystem and beta-lactamase activity 160
Health-promoting properties of new lactobacilli strains: in-vivo models 160
Assessment of novel probiotic Lactobacillus casei strains strains for the production of functional dairy foods. 160
EFFETTI DI FLUOROCHINOLONI IN LINFOCITI DI PAZIENTI IN TRATTAMENTI PROTRATTI. 159
Interazione itraconazolo-ciprofloxacina nel compartimento intestinale del ratto: dati preliminari 159
BACTERIAL ADHESION ON ANTIBIOTIC-LOADED POLYMETHYLMETHACRYLATE BONE CEMENT 159
Fluoroquinolones (FQs) effects on enterocytes and lymphocytes. 157
Prophylaxis of P. carinii pneumonia (PCP). in HIV-infected patients with trimethoprim/sulfametoxazole (TMP/SMX) or dapsone (DDS) 156
Microflora intestinale ed enzimi fecali in donne con fibromatosi uterina e tumore al seno. 153
Dose-effect of fluoroquinolones on intestinal penetration, hepatic isoforms and DNA damage in the rat 153
Effect of probiotics in the presence of antimicrobial therapy 152
Effect of pancreatic enzymes administration on intestinal ecosystem in patients with exocrine pancreatic insufficiency. Preliminary results 151
Itraconazole-ciprofloxacin interaction on the pharmacokinetics of the intestinal compartment: preliminary results in rats 151
A different behaviour of antibiotics in presence of fresh intestinal content in vitro. 150
A serum antimicrobial activity of cancer patients and interaction with different antibacterial drugs. 149
Alterazioni dell’ecosistema inestinale da antibiotici. problemi e prospettive 149
Effetti sistemici ed intestinali dei fluorochinoloni 146
Health promoting of new Lactobacilli strains: in-vivo models. 146
Intestinal ecosystem and metabolic capacity in women with breast cancer 145
Bacterial adhesion on antibiotic-loaded polymethylmethacrylate bone cement 145
Valutazione della compliance al dapsone (DDS) in pazienti in profilassi per PCP. 144
Twice-weekly dapsone for primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1 infection: comparative efficacy and pharmacokinetic data. 141
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer. 140
CEFTRIAXONE THERAPY, INTESTINAL BETA-LACTAMASES AND INTERACTION WITH PROBIOTICS IN CHILDREN 140
Release of gentamicin and vancomycin from preformed spacers in infected total hip arthroplasties: Measurement of concentrations and inhibitory activity in patients' drainage fluids and serum 140
Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer 139
Variability in the release of antibiotics from PMMA bone cement spacers 139
Attività antimicrobica del siero di pazienti cancerosi ed interazioni farmacologiche con diversi farmaci antibatterici 138
Commercial probiotic products: evaluation of microbial content and nomenclature. 138
Rilascio di antibiotici da spaziatori antibiotati nei fluidi di drenaggio 137
Changes in rat intestinal microflora following oral and parenteral administration of antimicrobial drugs 136
Attività degli antibiotici nei sistemi biologici 135
DRAINAGE AND SERUM LEVELS OF ANTIBIOTICS FOLLOWING TEMPORARY SPACER IMPLANTS IN TWO-STAGE REVISION SURGERY 135
Microbiological and pharmacological tests on new antibiotic-loaded PMMA-based composites for the treatment of osteomyelitis 134
Piperacillin-Tazobactam penetration into human pancreatic juice 133
Vancogenx-space for hip and knee: gentamicin and vancomycin levels in serum and urine from a multicenter trial 133
Metronidazole (MZ) penetration into pancreatic juice (P5) and necrotic pancreatic tissue (NPT). 132
Different effect of pre-treatment with phenobarbital on transintestinal elimination of moxifloxacin and ciprofloxacin: preliminary data 129
Release of gentamicin and vancomycin alone and in combination from polymethylmethacrylate (PMMA) cement 128
Rilascio locale dell’associazione gentamicina-vancomicina da chiodo endomidollare in osteomielite sperimentale 128
Release of antibiotics from polymethylmethacrylate cement 127
Immunosuppression and antimicrobial drugs: effects on rats intestinal microflora. 127
Trattamento con fluorochinoloni ed effetti su linfociti di pazienti in politerapia prolungata 127
Diffusion into bone tissue of gentamicin-vancomycin combination from PMMA device in experimental osteomyelitis and in vitro bacterial adhesion to PMMA 126
Rischio di nefrotossicità per terapia locale con cementi ossei antibiotati (aminoglicosidi e glicopeptidi) nelle infezioni protesiche. 126
Antibiotic release from removed temporary hip spacers 126
Preliminary evaluation of probiotic properties of L. casei strains 125
Composition and metabolic activity of the intestinal microflora in pre- and postmenopausal women with breast cancer 125
Behaviour of antibiotics during human necrotizing pancreatitis. 125
DOSE-EFFECTS OF FLUOROQUINOLONES (FQs) ON INTESTINAL PENETRATION, HEPATIC ISOFORMS AND DNA DAMAGE IN RAT. 125
Premenstrual syndrome (PMS): effect of probiotic supplement and S-adenosyl-L-methionine (SAMe) on intestinal microflora. 124
Combination of immunosuppressive treatment and antimicrobial drugs: effect on colonic microflora of rat. 124
Continuous Infusion of Flumazenil in the Management of Benzodiazepines Detoxification 124
Attività degli antibiotici nei sistemi biologici 123
Interleuchina –4 e ossido nitrico nella pancreatite cronica umana. 123
Pk-pd parameters ratio of antibotics released from antibiotic-loaded spacers in drainage fluids. 123
Intestinal microflora composition in premenstrual syndrome (PMS) and effect of Lactobacillus-Bifidobacterium administration 122
Behavior of antibiotics during human necrotizing pancreatitis. 121
Pefloxacin penetration into human necrotic pancreatic tissue. 121
Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriazone 120
Improvement of intestinal balance in chronic pancreatitis insufficiency (CPI) by antibiotic and probiotic administration. 120
Interazione positiva fra succo pancreatico e antibatterici. 120
Effect of pancreatic enzymes administration on intestinal ecosystem in patients with exocrine pancreatic insufficiency 120
Diverso effetto del pretrattamento con fenobarbital sull'eliminazione transintestinale di moxifloxacina e ciprofloxacina: dati preliminari 120
Effects of itraconazole on the pharmacokinetics of ciprofloxacin and the intestinal metabolizing system (CYP450 and P-glycoprotein) 120
Potential probiotics benefit in gastrointestinal disorders of different aetiology. 119
Metronidazole (MZ) penetration into pancreatic juice and necrotic pancreatic tissue (NTP). 119
Release of antibiotics and inhibitory activity in drainage fluids following temporary spacer implants in two-stage revision surgery 119
Changes in rat intestinal microflora following oral and parenteral administration of antimicrobial drugs. 118
Totale 18.896
Categoria #
all - tutte 75.255
article - articoli 28.211
book - libri 0
conference - conferenze 43.698
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.346
Totale 150.510


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.081 0 0 0 0 0 235 45 180 173 55 299 94
2021/20221.513 124 384 38 112 60 55 46 76 70 61 134 353
2022/20233.386 266 285 353 540 314 674 64 252 307 50 188 93
2023/20241.949 85 159 136 254 198 237 120 206 49 105 224 176
2024/20253.993 291 391 205 583 285 83 187 203 617 197 243 708
2025/20265.664 676 411 621 1.243 2.066 647 0 0 0 0 0 0
Totale 26.704